Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tomudex and Cisplatin Versus Cisplatin in Malignant Pleural Mesothelioma
NCT00004920Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Nov 1999
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of raltitrexed in malignant pleural mesothelioma (MPM), sponsored by European Organisation for Research and Treatment of Cancer. Started Nov 1999; status: completed.
02
Drugs
raltitrexed
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00004920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004920.